Featured Content |View More
A case underscoring risk-stratified screening, symptom vigilance, and referral to advanced endoscopy expertise.
Adventist Health Glendale Introduces Pulsed Field Ablation for Atrial Fibrillation
Adventist Health Glendale is among a select group of centers now offering Pulsed Field Ablation (PFA) for atrial fibrillation, bringing a next-generation, non-thermal energy source into routine EP practice. This tissue-selective technology ...
Adventist Health Glendale Completes 100th Ion Robotic Bronchoscopy
A year after performing its first robotic bronchoscopy, Adventist Health Glendale has completed its 100th case using the Ion endoluminal system. The rapid growth of the program reflects strong regional demand for advanced lung nodule evaluation ...
Adventist Health Glendale’s James Tabibian, MD, Medical Director of Adventist Health Glendale’s Digestive Diseases Center recently served as a co-investigator (Tabibian et al, 2025) in a systematic review and meta-analysis evaluating ...
Precision Radiosurgery: Non-Surgical Breakthrough in Managing Complex Brain Metastases
When surgery is no longer an option, can advanced radiosurgery restore neurologic function in patients with deep-seated brain metastases? See what the Medical Director of Radiation Oncology described as his most interesting case of the year.
Adventist Health Glendale Earns Full Five-Year Reaccreditation of Its Institutional Review Board
Adventist Health Glendale has been awarded Full Five-Year Reaccreditation by the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP) — the highest level of recognition granted by the nation’s leading ...
Interventional Pulmonology Detects the Undetectable
Ramyar Mahdavi, MD, interventional pulmonologist at Adventist Health Glendale, discusses a complex case of adenocarcinoma that evaded diagnosis elsewhere.
Functional GI Expert Shares Remission Breakthrough in Refractory Ulcerative Colitis
Gastroenterologist Tina Storage, MD, discusses the application of a newly approved oral agent in the case of a 29-year-old male with severe, treatment-resistant UC.
Interventional Cardiology Insight: Managing Acute Mitral Regurgitation
Dr. Harry Balian describes the rapid deterioration of a patient with torrential mitral regurgitation — and the decisive intervention that followed.